- AP - Eli Lilly & Co. has agreed to spend more than $6 billion to fortify its cancer treatment portfolio by acquiring the biotechnology firm ImClone Systems Inc. in a deal that tops earlier offers from competitor Bristol-Myers Squibb Co. - 
Reuters - Eli Lilly and Co has agreed to acquire ImClone Systems Inc for $6.5 billion, outbidding Bristol-Myers Squibb Co and potentially bringing to a close one of the most colorful corporate sagas in biotech history.
- 
AFP - US pharmaceutical company Eli Lilly said Monday it had agreed a takeover worth 6.5 billion dollars with biotech firm ImClone, which is also a target for rival Bristol-Myers Squibb (BMS).
- 
Reuters - ImClone Systems Inc is in talks to be acquired by Eli Lilly and Co , sources familiar with the situation said on Wednesday, after ImClone had rebuffed a sweetened takeover offer from Bristol-Myers Squibb Co .
- AP - Drugmaker Eli Lilly & Co. reportedly is the secret suitor that's been courting ImClone Systems Inc. and is offering approximately $6.1 billion for the biotech company. - AP - Congress has passed a bill intended to crack down on rogue online pharmacies that sell drugs without a valid prescription. - AP - Federal health regulators delayed a decision on a blood thinner from Eli Lilly for a second time Friday, raising concerns on Wall Street about the potential blockbuster medication. - 
AP - The state of California has a warning for its 36 million residents: Do not flush pharmaceuticals down the toilet or drain, or they may end up in a river near you.
- 
Reuters - Retailers that have rolled out low-cost generic prescription programs cannot rely on cheaper drugs alone to lure customers, especially if they skimp on good service, a new J.D. Power and Associates survey found.
- AP - Eli Lilly and Co. aims to grow leaner and more diverse as it pushes to keep pace with changes spreading through the drug industry, CEO John Lechleiter said in a Wednesday afternoon speech. - AP - In an industry first, Eli Lilly and Co. says it will begin disclosing how much money it paid to individual doctors nationally for advice, speeches and other services. - 
AFP - The US Food and Drug Administration on Tuesday warned pharmaceutical laboratories to stop marketing two unapproved products that have been linked to serious health problems.
- AP - Big pharmaceutical companies and their biotech cousins will likely weather the financial crisis engulfing Wall Street, several analysts said, because of the necessity of their products and cash-rich balance sheets. - 
Reuters - Walgreen Co said on Monday it may launch a hostile takeover for Longs Drug Stores Corp if its smaller pharmacy chain rival fails to open merger talks.
- AP - Pfizer Inc. is dramatically stepping up sales efforts in emerging markets, overhauling U.S. business operations and slashing more costs ahead of the 2011 patent loss for cholesterol blockbuster Lipitor, its head of pharmaceutical operations said Monday.
